昂丹司琼预防剖宫产鞘内阿片相关瘙痒的系统评价与荟萃分析
BACKGROUND: Pruritus is a frequently reported and unpleasant side effect following intrathecal opioid use with frequency further increased among parturients.…
要点
- 昂丹司琼可降低剖宫产鞘内阿片后瘙痒发生率(RR 0.81)。
- 对瘙痒发生时间无显著影响(MD 17.54分钟,95%CI -2.18至37.26)。
- 证据质量低、异质性高,需高质量研究确认。
核心结论
- 昂丹司琼可显著降低剖宫产脊麻鞘内阿片患者的瘙痒发生率。
研究设计与样本
- 系统评价与荟萃分析,检索MEDLINE、Embase、Cochrane和Web of Science至2022年9月。
主要发现
- 昂丹司琼组瘙痒发生率显著低于对照组(RR 0.81,95%CI 0.71-0.92,I²=64%)。
- 两组瘙痒发生时间无显著差异(MD 17.54分钟,95%CI -2.18至37.26,I²=83%)。
- 纳入研究使用的鞘内阿片为吗啡、芬太尼和舒芬太尼。
关键数值与推荐
- GRADE证据质量总体评为低。
- 主要结局为瘙痒发生,次要结局为瘙痒发生时间。
临床怎么用
- 剖宫产脊麻鞘内阿片患者可考虑使用昂丹司琼预防瘙痒,但需结合低证据质量个体化决策。
局限性
- 纳入研究质量不一,部分存在高偏倚风险。
- 统计异质性高(主要结局I²=64%,次要结局I²=83%)。
- 证据质量低,需高质量、足够把握度的研究确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Pruritus is a frequently reported and unpleasant side effect following intrathecal opioid use with frequency further increased among parturients. We have performed a systematic review to assess the overall efficacy of ondansetron for the prevention of pruritus in patients receiving intrathecal opioid as part of spinal anesthesia for cesarean delivery. METHODS: A literature search of MEDLINE, Embase, Cochrane, and Web of Science databases was conducted from date of inception to September 2022. Studies that included patients undergoing cesarean delivery with spinal anesthesia using intrathecal opioid were included. The primary outcome was the presence of pruritus, and the secondary outcome was time to onset of pruritus. Data from included studies were pooled for analysis using an appropriately determined random-effects model. Outcomes were presented using forest plots and 95% confidence intervals. Additional sensitivity and subgroup analysis were performed. Trial sequential analysis was conducted for the primary outcome. RESULTS: Twenty-three randomized controlled trials with a total of 2586 patients were included: 1219 received ondansetron, 1030 received a placebo, and a further 337 received a different study drug and were excluded from analysis. Opioids used in the included studies were morphine, fentanyl, and sufentanil. Patients who received ondansetron showed a significant reduction in the incidence of pruritus compared to the control group (RR, 0.81; 95% confidence interval [CI], 0.71-0.92; I 2 = 64%). There was no significant difference in pruritus onset between the groups (mean difference [MD], 17.54 minutes; 95% CI, -2.18 to 37.26; I 2 = 83%). The overall Grading of Recommendations Assessment, Development, and Evaluation (GRADE) assessment of quality of evidence was low. CONCLUSIONS: This systematic review has demonstrated a significant reduction in the incidence of pruritus following the use of ondansetron. This is in contrast to previously published meta-analyses. Studies included were of varying quality and some at high risk of bias with a high degree of statistical heterogeneity. Furthermore, high-quality and well-powered studies are required to confirm these findings.
引用
- Cadd M, Jackson P, Ewnetu B, et al. Ondansetron for the Prevention of Pruritus in Women Undergoing Cesarean Delivery With Intrathecal Opioid: A Systematic Review and Meta-Analysis. Anesth Analg. 2023. PMID: 37167702. doi:10.1213/ANE.0000000000006526
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。